GINO BIOW Stock Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 193M | Sales 2025 * | 252M | Capitalization | 1.78B |
---|---|---|---|---|---|
Net income 2024 * | -579M | Net income 2025 * | -421M | EV / Sales 2024 * | 6.08 x |
Net cash position 2024 * | 610M | Net cash position 2025 * | 565M | EV / Sales 2025 * | 4.83 x |
P/E ratio 2024 * |
-2.8
x | P/E ratio 2025 * |
-3.58
x | Employees | 1,218 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.85% |
Latest transcript on GINO BIOW
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 07-12-31 |
Founder | - | 07-12-31 | |
Reshma Shetty
FOU | Founder | 43 | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 21-09-15 |
Arie Belldegrun
BRD | Director/Board Member | 74 | 20-12-31 |
Marijn Dekkers
CHM | Chairman | 65 | 21-09-15 |
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |